| Dr Melissa Crchova, MD | |
|
460 Main St, Suite 104, Madawaska, ME 04756-1014 | |
| (207) 728-6359 | |
| (207) 728-7614 |
| Full Name | Dr Melissa Crchova |
|---|---|
| Gender | Female |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 460 Main St, Madawaska, Maine |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245414002 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZC0006X | Pathology - Clinical Pathology | K5085 (Texas) | Secondary |
| 2084P0800X | Psychiatry & Neurology - Psychiatry | K5085 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Melissa Crchova, MD 460 Main St, Suite 104, Madawaska, ME 04756-1014 Ph: (207) 728-6359 | Dr Melissa Crchova, MD 460 Main St, Suite 104, Madawaska, ME 04756-1014 Ph: (207) 728-6359 |
News Archive
Northstar Healthcare Inc. today announced that it plans to complete a non-brokered private placement of common shares to Canada Healthcare Acquisition Inc., a corporation indirectly controlled by Dr. Donald L. Kramer, M.D., a former CEO and former director of Northstar.
Axolotl Corp., the nationwide leader in health information exchange (HIE) solutions and services and Rochester RHIO, the regional health information organization connecting medical providers across nine counties in New York today announced that fifty area eldercare agencies are joining the health information exchange. For the first time anywhere, health care providers are now able to view medical and social supports that human service agencies provide senior patients, alongside their clinical information.
PolyTherics Ltd, a biopharmaceutical company specialised in the targeted application of polymers to biopharmaceuticals, and Alligator Bioscience AB ("Alligator"), a biotechnology company applying proprietary technology to the improvement of proteins, today announced the establishment of a new alliance.
ShangPharma Corporation, a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced commencement of operations on the initial phase of production at the Company's Fengxian facility. This new multi-purpose pharmaceutical development and cGMP manufacturing facility is located in Fengxian in the suburbs of Shanghai, China.
A new study from Sweden found that social benefits often ease the financial burdens experienced by the parents of children recently diagnosed with cancer, but mothers experienced persistently lower income after benefits diminished.
› Verified 3 days ago